Berberine and its more bioavailable derivative dihydroberberine inhibit mitochondrial complex I: a mechanism for the action of berberine to activate AMP activated protein kinase and improve insulin action
Diabetes, 2010
Each vegan capsule delivers 500 mg of 97% pure berberine hydrochloride (berberine HCl), extracted from Berberis aristata root. At the recommended dose of 1 capsule twice daily with meals, each daily serving provides 1,000 mg of berberine HCl the dose used in the majority of clinical berberine research. Activates AMPK through five complementary mechanisms to support healthy blood glucose metabolism.
Berberine (berberina) is a quaternary ammonium alkaloid found in the root of Berberis aristata (barberry) and several other plants. It is one of the most extensively studied botanical compounds in metabolic health research. This pure berberine HCl supplement delivers 97% pure berberine hydrochloride the most bioavailable and research supported berberine salt form in a clean vegan capsule with only three non medicinal ingredients.
This berberine AMPK activator supports healthy glucose metabolism through five distinct and complementary pathways:
1. AMPK activation: Berberine inhibits mitochondrial complex I, raising the AMP to ATP ratio and triggering the AMPK signalling cascade governing glucose uptake, fatty acid oxidation, and suppression of gluconeogenesis. This berberine AMPK mechanism is analogous to that of metformin, though berberine operates through partially distinct downstream pathways.
2. GLUT4 translocation: AMPK activation promotes insulin-independent GLUT4 transporter translocation to skeletal muscle cell membranes, increasing cellular glucose uptake even in conditions of reduced insulin sensitivity.
3. Reduced hepatic glucose output: Berberine-mediated AMPK activation in hepatocytes downregulates PEPCK and G6Pase, suppressing gluconeogenesis and glycogenolysis and reducing fasting glucose output from the liver.
4. Alpha glucosidase inhibition: Berberine inhibits intestinal alpha glucosidase enzymes, slowing carbohydrate digestion and blunting the postprandial blood glucose rise making it important to take berberine HCl 500mg capsules with meals.
5. Gut microbiome modulation: Despite oral bioavailability estimated below 5%, berberine produces significant metabolic effects in the GI tract by selectively modulating gut microbiota, increasing short-chain fatty acid producing bacteria, and improving gut barrier integrity and insulin receptor expression.
Each vegan capsule delivers 500 mg of 97% pure berberine hydrochloride (berberine HCl), extracted from Berberis aristata root. At the recommended dose of 1 capsule twice daily with meals, each daily serving provides 1,000 mg of berberine HCl the dose used in the majority of clinical berberine research. Activates AMPK through five complementary mechanisms to support healthy blood glucose metabolism.
Berberine (berberina) is a quaternary ammonium alkaloid found in the root of Berberis aristata (barberry) and several other plants. It is one of the most extensively studied botanical compounds in metabolic health research. This pure berberine HCl supplement delivers 97% pure berberine hydrochloride the most bioavailable and research supported berberine salt form in a clean vegan capsule with only three non medicinal ingredients.
This berberine AMPK activator supports healthy glucose metabolism through five distinct and complementary pathways:
1. AMPK activation: Berberine inhibits mitochondrial complex I, raising the AMP to ATP ratio and triggering the AMPK signalling cascade governing glucose uptake, fatty acid oxidation, and suppression of gluconeogenesis. This berberine AMPK mechanism is analogous to that of metformin, though berberine operates through partially distinct downstream pathways.
2. GLUT4 translocation: AMPK activation promotes insulin-independent GLUT4 transporter translocation to skeletal muscle cell membranes, increasing cellular glucose uptake even in conditions of reduced insulin sensitivity.
3. Reduced hepatic glucose output: Berberine-mediated AMPK activation in hepatocytes downregulates PEPCK and G6Pase, suppressing gluconeogenesis and glycogenolysis and reducing fasting glucose output from the liver.
4. Alpha glucosidase inhibition: Berberine inhibits intestinal alpha glucosidase enzymes, slowing carbohydrate digestion and blunting the postprandial blood glucose rise making it important to take berberine HCl 500mg capsules with meals.
5. Gut microbiome modulation: Despite oral bioavailability estimated below 5%, berberine produces significant metabolic effects in the GI tract by selectively modulating gut microbiota, increasing short-chain fatty acid producing bacteria, and improving gut barrier integrity and insulin receptor expression.
Serving Size: 1 Capsule
Servings Per Container: 60
† Daily Value not established
Diabetes, 2010
Metabolism, 2008
Frontiers in Microbiology, 2020
Research information is provided for educational purposes and does not replace the product's approved label information.